Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Posaconazole for Aspergillus in Cystic Fibrosis (cASPerCF)
NCT04966234Phase 3Unknown
- Start
- Apr 2021
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 11
01
Overview
Phase 3, randomised, open-label trial of posaconazole in aspergillosis. Status: unknown.
02
Drugs
posaconazole
03
Conditions
aspergillosis
Beyond the preview
Go deeper on NCT04966234.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04966234.